剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

未开盘 08-19 16:08:46

11.720

-0.280

-2.33%

最高12.190	最低11.220	成交量122.24万
今开11.850	昨收12.000	日振幅8.08%
总市值138.65亿	流通市值126.93亿	总股本11.83亿
成交额1,423万	换手率0.11%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":11.72,"timestamp":1787126926582,"preClose":12,"halted":0,"volume":1222360,"delay":0,"changeRate":-0.02333333333333328,"floatShares":1083000000,"shares":1183000000,"eps":-5.425151334148732,"marketStatus":"未开盘","change":-0.28,"latestTime":"08-19 16:08:46","open":11.85,"high":12.19,"low":11.22,"amount":14232577,"amplitude":0.080833,"askPrice":11.79,"askSize":1000,"bidPrice":11.72,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.42746313850013723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787189400000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":12,"openAndCloseTimeList":[[1787103000000,1787112000000],[1787115600000,1787126400000]],"volumeRatio":0.457215,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"1169599675","title":"财报前瞻｜剂泰科技-P营收结构稳定，机构观点暂无明显分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=1169599675","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169599675?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:54","pubTimestamp":1787014472,"startTime":"0","endTime":"0","summary":"剂泰科技-P将于2026年08月25日发布最新季度财报，市场关注营收结构稳定性与利润修复节奏。目前缺乏一致预期数据与公司在上季度财报中对本季度收入、毛利率、净利润或净利率、调整后每股收益的明确预测信息，无法展示相应的详细预测。公司上一季度经营的重点在于维持高毛利率水平的同时承受净利润阶段性承压。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜剂泰科技-P营收结构稳定，机构观点暂无明显分歧","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659824391","title":"港股异动 | 剂泰科技-P(07666.HK)涨超8%实现五连阳 AI制药跨国合作项目加速落地 公司有望先行受益行业演进","url":"https://stock-news.laohu8.com/highlight/detail?id=2659824391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659824391?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:13","pubTimestamp":1786587185,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1191","01477","07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190663062","title":"剂泰科技-P（07666）公告董事会会议时间 将审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1190663062","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190663062?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:40","pubTimestamp":1786531231,"startTime":"0","endTime":"0","summary":"剂泰科技（北京）股份有限公司（股票代码：07666）12日发布公告称，董事会已定于2026年8月25日（星期二）召开会议。\n本次会议的主要议程包括：  \n1. 审议并批准本集团截至2026年6月30日止六个月的未经审计中期业绩；  \n2. 研究及决定是否派发中期股息（如有）；  \n3. 处理其他事项。\n公告显示，目前公司董事会成员包括执行董事赖才达博士、Hongming Chen博士及王文首博士；非执行董事黄瀚涛先生及公元女士；以及独立非执行董事林怡仲先生、李晋博士和Peter Edward Lobie博士。\n公司董事会主席、执行董事兼首席执行官赖才达已在公告中签署确认。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928924","title":"剂泰科技-P盘中涨近8% 本月内股价累计涨幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928924","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658928924?lang=zh_cn&edition=full","pubTime":"2026-08-12 11:24","pubTimestamp":1786505040,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端剂泰科技-P（07666）盘中涨近8%，本月内股价累计涨幅已超30%。截至发稿，股价上涨6.29%，现报13.01港元，成交额3184.84万港元。申万宏源发布研报称，剂泰科技以纳米材料以及药物递送为核心的AI4S平台，本质上属于高壁垒、强前瞻的“未来科技”，其估值逻辑不应囿于业务完全相同的历史标的，而应参照同一时期市场赋予相似技术属性的高景气赛道。中信建投则表示，随着NanoForge和AI平台持续拓展对外合作，双轮驱动模式不断验证，看好剂泰科技在AI驱动的小分子药物制剂开发领域的长期价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-12/doc-inimzqcv4056999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658940085","title":"港股异动 | 剂泰科技-P(07666.HK)再涨近8% 机构指AI4S将成为继Coding之后下一个大场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2658940085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658940085?lang=zh_cn&edition=full","pubTime":"2026-08-12 10:55","pubTimestamp":1786503312,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658443961","title":"港股异动 | 剂泰科技-P(07666.HK)再涨超7% 8月初至今累涨近三成 已连续多日领涨AI制药板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2658443961","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658443961?lang=zh_cn&edition=full","pubTime":"2026-08-11 12:59","pubTimestamp":1786424368,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","01477","BK1191","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658132604","title":"剂泰科技-P持续获市场资金追捧 午前股价涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658132604","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658132604?lang=zh_cn&edition=full","pubTime":"2026-08-10 11:37","pubTimestamp":1786333020,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端剂泰科技-P（07666）持续获市场资金追捧，早盘一度涨超20%，继续领涨AI制药板块。截至发稿，涨幅收窄，股价上涨7.19%，现报11.92港元，成交额8510.08万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-10/doc-inimuzxt4978525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658015776","title":"港股异动 | AI和创新药双向加持 剂泰科技-P(07666.HK)早盘涨超19% 继续领涨AI制药板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2658015776","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658015776?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:05","pubTimestamp":1786327542,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","06978","01477","BK1191","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097936","title":"AI医疗概念股普升 剂泰科技-P（07666）涨12.86%、晶泰控股（02228）涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097936","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097936?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:03","pubTimestamp":1786327392,"startTime":"0","endTime":"0","summary":"金吾财讯 | AI医疗概念股盘初普升，截至发稿，剂泰科技-P 涨12.86%，晶泰控股涨10.26%，英硅智能涨9.38%，百奥赛图-B涨8.33%，讯飞医疗科技涨4.98%，医渡科技涨4.00%，云知声涨3.96%，平安好医生涨3.58%，阿里健康涨3.21%，京东健康涨2.98%。AIDD有望重塑早期药物发现的流程，大大加速早期药物筛选的效率及成功率，相关干实验投入的增加以及对湿实验需求持续的增长，有望为下游产业链持续带来增量。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987779","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1518","BK1502","BK1501","BK1591","BK1515","BK1247","BK1142","SGXZ62798434.SGD","BK1109","03696","BK1615","HK0000165453.HKD","QTOC","BK1617","00241","BK1571","AIPO","CHAT","09678","BK1610","BK1189","BK1161","BK1219","VTHR","02506","02158","01833","LU0051755006.USD","AGIX","BK1584","86618","LU0456827905.SGD","BK1589","159891","07666","06618","ARTY","BK1583","SGXZ86797644.SGD","BK1141","02228","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658760987","title":"港股异动 | 剂泰科技-P(07666)早盘涨超16% 自研AiTEM人工智能制剂平台落地恒瑞医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2658760987","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658760987?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:36","pubTimestamp":1786325777,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P早盘涨超16%，截至发稿，涨15.74%，报12.87港元，成交额1300.47万港元。消息面上，剂泰科技近日公告，公司自主研发的AiTEM人工智能制剂创新平台将在恒瑞医药进行本地化部署，加速药物制剂配方开发效率。据悉，AiTEM曾赋能剂泰科技自研管线MTS-004的剂型开发，将临床前制剂优化周期从行业平均的1-2年缩短至3个月内完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIFD","NJUL","MVPS","GPIQ","KOMP","VXUS","SQQQ","TQQY","KCAI","NEWZ","NAPR","OGIG","TQQQ","01276","QQQX","AQGX","600276","QQQM","TECY","GK","MFIG","NJAN","QSWN","PBOT","NOCT","07666","161631","QLD","VUSE","FWD","NBDS","DQJN","CWC","QMAR","QQQ","CHAT","QDEC","ARTY","PSQ","LCLG","QID","TARK","WPAI","AIQU","QQA","AGIX","CPNQ","QTOC","AIBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516695","title":"港股异动 | AI制药商业化兑现能力逐步凸显 剂泰科技-P(07666.HK)大涨超7%领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657516695?lang=zh_cn&edition=full","pubTime":"2026-08-07 11:51","pubTimestamp":1786074686,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1191","07666","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657693089","title":"港股异动 | 创新药概念多数走高 创新药企陆续迎业绩窗口 后续学术会议有望带来密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2657693089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657693089?lang=zh_cn&edition=full","pubTime":"2026-08-07 11:24","pubTimestamp":1786073069,"startTime":"0","endTime":"0","summary":"消息面上，近期多家创新药企业陆续发布业绩相关公告。从百济神州净利润同比增超6倍，到药明康德大幅上调全年收入指引，再到信达生物、荣昌生物各自兑现增长逻辑，创新药产业链正迎来\"业绩落地+催化密集\"的共振窗口。值得一提的是，海外顶级医学会议临床数据披露有望成为短期核心催化。其次，该行长期看好国产创新药发展趋势，行业景气度向上，出海持续演绎，后续学术会议陆续召开，临床数据有望读出，带来密集催化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","02268","LU0823426308.USD","LU1794554557.SGD","BK1588","LU1242518931.SGD","02269","06978","LU0359202008.SGD","LU0708995583.HKD","LU0307460666.USD","LU0181495838.USD","LU0348825331.USD","KURE","01672","LNGR","LU0348735423.USD","09688","159992","LU0979878070.USD","LU2039709279.SGD","LU0856984785.SGD","BK1515","LU0051755006.USD","07666","KCAI","LU0043850808.USD","LU2488822045.USD","LU0417516738.SGD","SG9999002463.SGD","LU0516422366.SGD","BK1589","MEDX","BK1574","LU0039217434.USD","LU0819121731.USD","BK1161","BK1521","LU0572944931.SGD","LU0456846285.SGD","LU0326950275.SGD","LU0327786744.USD","SG9999002562.SGD","LU0823426480.USD","LU0359201612.USD","LU1720050803.USD","VXUS","LU0417516902.SGD","LU1880383366.USD","LU3063872942.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186519546","title":"剂泰科技-P7月股份变动月报：股本维持不变，少量购股权失效","url":"https://stock-news.laohu8.com/highlight/detail?id=1186519546","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186519546?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:37","pubTimestamp":1786005434,"startTime":"0","endTime":"0","summary":"剂泰科技(北京)股份有限公司 - P于2026年8月6日披露2026年7月股份变动月报表。报告期为截至2026年7月31日止一个月。截至2026年7月31日，公司已发行股本总数合计1,182,697,850股，较上月底保持不变，并未进行任何新增发行、回购或注销股份等活动。公告同时披露，日均公众持股量符合香港联交所相关上市规则要求。公司表示，未来仍将继续严格遵守香港联交所《上市规则》及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129175084","title":"剂泰科技-P（07666）获港交所豁免　委任曹楠为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=1129175084","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129175084?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:05","pubTimestamp":1785848730,"startTime":"0","endTime":"0","summary":"2026年8月4日，剂泰科技（北京）股份有限公司公告称，公司董事会已委任曹楠为公司秘书，自2026年8月4日起生效。曹楠将与已具备香港《上市规则》第3.28条规定资格及相关经验的陈曦共同担任联席公司秘书。在豁免期结束前，公司须向联交所证明曹楠已取得相关经验并具备履行《上市规则》第3.28条下公司秘书职能的能力，届时可无需进一步豁免。若公司情况发生变化，联交所可撤回或更改该豁免。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559454","title":"剂泰科技-P(07666.HK)：曹楠已获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559454","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656559454?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:04","pubTimestamp":1785848685,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656328510","title":"港股异动 | 剂泰科技-P(07666.HK)午后涨近7% AiTEM在恒瑞医药完成本地化部署 公司AI4S研发基础设施加速演进","url":"https://stock-news.laohu8.com/highlight/detail?id=2656328510","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656328510?lang=zh_cn&edition=full","pubTime":"2026-08-03 13:33","pubTimestamp":1785735234,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01276","07666","LU0359201885.HKD","LU2543165471.USD","BK1191","BK1161","LU0359202008.SGD","LU1023057109.AUD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656472693","title":"剂泰科技(07666)AI制剂创新平台落地恒瑞医药 NanoForge商业化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2656472693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656472693?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:17","pubTimestamp":1785730667,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月3日，剂泰科技宣布，公司自主研发的AiTEM人工智能制剂创新平台将在恒瑞医药完成本地化部署，用于加速药物制剂配方开发效率。此次合作标志着由NanoForge驱动的AiTEM人工智能制剂平台实现持续对外商业化落地，也意味着NanoForge作为AI4S研发基础设施加速演进。据了解，NanoForge是剂泰科技自主研发的AI纳米递送平台，集成AI脂质生成算法、脂质基础模型、智能体及高通量实验闭环平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2543165471.USD","LU1997245094.SGD","LU0359202008.SGD","BK0188","LU1328615791.USD","LU1064130708.USD","LU1997245177.USD","LU0359201612.USD","LU2580892862.HKD","BK0060","CHAT","LU0405327148.USD","AGIX","LU2289578879.USD","LU2488822045.USD","600276","BK0183","LU1023057109.AUD","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","LU2580892789.USD","LU2097828805.USD","LU1820825898.SGD","BK0196","ARTY","LU1146622755.USD","LU1997244956.HKD","AIPO","BK1191","01276","QTOC","LU2097828631.EUR","BK0028","LU1655091616.SGD","LU2495084118.USD","VTHR","BK0239","BK0012","LU2328871848.SGD","LU0359201885.HKD","LU2097828474.EUR","LU1580142542.USD","07666","LU0405327494.USD","LU2148510915.USD","LU2097828557.USD","LU1969619763.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144881122","title":"剂泰科技-P宣布AiTEM平台落地恒瑞医药　推动AI制剂商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1144881122","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144881122?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:12","pubTimestamp":1785730364,"startTime":"0","endTime":"0","summary":"2026年8月3日，剂泰科技-P发布自愿公告称，公司自主研发的 AiTEM 人工智能制剂创新平台将于江苏恒瑞医药股份有限公司落地部署，用于加速药物制剂配方开发。这是 Nanoforge 驱动的 AiTEM 平台继内部应用后在外部实现商业化闭环的最新进展。NanoForge 是目前全球首个 AI 驱动的纳米递送平台。公司简介显示，剂泰科技成立于 2020 年，于 2026 年5月13日在香港交易所挂牌，定位“全球 AI 药物递送第一股”。公司在公告中提醒股东及潜在投资者，对任何前瞻性陈述保持审慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655587361","title":"剂泰科技-P(07666)：付翀辞任首席财务官、董事会秘书、联席公司秘书等职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2655587361","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655587361?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:12","pubTimestamp":1785503521,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P(07666)公布，付翀博士因工作变动，已辞任公司首席财务官、董事会秘书、联席公司秘书、及法律程序代理人，自2026年8月1日起生效。公司另一名联席公司秘书陈曦女士将留任并继续担任公司的公司秘书，并同时获任公司法律程序代理人，其担任法律程序代理人自2026年8月1日起生效。自2026年8月1日起，公司将任命彭骏先生将担任公司董事会秘书，王榭女士获委任为公司财务负责人，直接向首席执行官汇报工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技-P(07666)：付翀辞任首席财务官、董事会秘书、联席公司秘书等职务","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146104940","title":"剂泰科技-P发布高管变动公告：首席财务官付翀辞任 彭骏、王榭履新","url":"https://stock-news.laohu8.com/highlight/detail?id=1146104940","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146104940?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:11","pubTimestamp":1785503479,"startTime":"0","endTime":"0","summary":"2026年7月31日，剂泰科技（北京）股份有限公司在港交所公告称，公司管理层将自2026年8月1日起迎来多项人事调整。在职务交接方面，现任联席公司秘书陈曦女士将继续担任公司秘书，并自2026年8月1日起兼任法律程序代理人。陈曦女士具备上市规则第3.28条规定的公司秘书专业资格及相关经验。董事会对付翀博士的贡献表示感谢，并对彭骏先生及王榭女士的到任表示欢迎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.0713},{"period":"1month","weight":0.1015},{"period":"3month","weight":-0.2841},{"period":"6month","weight":0.1162},{"period":"ytd","weight":0.1162}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0043},{"period":"6month","weight":-0.0348},{"period":"1year","weight":0.0148},{"period":"ytd","weight":-0.0053}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}